AngioDynamics, Inc. (ANGO:NASDAQ) closed at $11.87 on November 13, 2026, down 0.96% on the day. The stock trades 27.1% below its 52-week high of $16.29 and 26.4% above its 52-week low of $9.39. Over the past year, it lost 2.0%. AngioDynamics, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since November 13, 2025, ANGO closed higher on 125 days (50%). Its best day was July 15, 2026 (+11.31%) and its worst was October 8, 2026 (-20.86%). The stock moved 10% or more in a single session 4 times.
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices for vascular access, surgery, peripheral vascular disease, and oncology in the United States and internationally. The company provides manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; VenaCure EVLT laser system products to treat superficial venous diseases; Asclera drug for treating uncomplicated spider and reticular veins of the lower extremities; and Sotradecol drugs for treating small uncomplicated varicose veins of the lower extremities. It also offers AngioVac venous drainage system that includes venous drainage cannula for the removal of fresh, soft thrombi, or emboli during extracorporeal bypass; and cardiopulmonary bypass circuit for use in procedures during extracorporeal circulatory support. In addition, the company provides thrombolytic catheters to deliver thrombolytic agents; angiographic products and accessories for use in during peripheral vascular interventional procedures; drainage p...
Find more stocks like ANGO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.